UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial

Nature medicine, 2022-02, Vol.28 (2), p.401-409

2022

Volltextzugriff (PDF)

Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study

Nature medicine, 2021-06, Vol.27 (6), p.1062-1070

2021

Volltextzugriff (PDF)

Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need

Signal transduction and targeted therapy, 2021-02, Vol.6 (1), p.48-48, Article 48

2021

Volltextzugriff (PDF)

Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China

The New England journal of medicine, 2014-02, Vol.370 (9), p.818-828

2014

Volltextzugriff (PDF)

CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2

Human vaccines & immunotherapeutics, 2022-11, Vol.18 (6), p.2096970-2096970

2022

Volltextzugriff (PDF)

Structures of Echovirus 30 in complex with its receptors inform a rational prediction for enterovirus receptor usage

Nature communications, 2020-09, Vol.11 (1), p.4421-4421, Article 4421

2020

Volltextzugriff (PDF)

A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)

Virology (New York, N.Y.), 2020-10, Vol.549, p.1-4

2020

Volltextzugriff (PDF)

Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial

PLoS medicine, 2022-05, Vol.19 (5), p.e1003953-e1003953

2022

Volltextzugriff (PDF)

Serotype specific epitopes identified by neutralizing antibodies underpin immunogenic differences in Enterovirus B

Nature communications, 2020-09, Vol.11 (1), p.4419-4419, Article 4419

2020

Volltextzugriff (PDF)

Research progress in the off-target effects of Bacille Calmette-Guérin vaccine

Chinese medical journal, 2024-09, Vol.137 (17), p.2065-2074

2024

Volltextzugriff (PDF)

Advances in the progress of monoclonal antibodies for rabies

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (1), p.2026713-2026713

2022

Volltextzugriff (PDF)

HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV

Journal of virology, 2021-01, Vol.95 (4)

2021

Volltextzugriff (PDF)

COVID-19 in children: epidemic issues and candidate vaccines

Chinese medical journal, 2022-06, Vol.135 (11), p.1314-1324

2022

Volltextzugriff (PDF)

Rapid and Sensitive Detection of Salmonella spp. Using CRISPR-Cas13a Combined With Recombinase Polymerase Amplification

Frontiers in microbiology, 2021-10, Vol.12, p.732426-732426

2021

Volltextzugriff (PDF)

Ebola vaccines in clinical trial: The promising candidates

Human vaccines & immunotherapeutics, 2017-01, Vol.13 (1), p.153-168

2017

Volltextzugriff (PDF)

The performance of licensed rotavirus vaccines and the development of a new generation of rotavirus vaccines: a review

Human vaccines & immunotherapeutics, 2021-03, Vol.17 (3), p.880-896

2021

Volltextzugriff (PDF)

An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Signal transduction and targeted therapy, 2021-04, Vol.6 (1), p.165-165, Article 165

2021

Volltextzugriff (PDF)

Dynamic reassortments and genetic heterogeneity of the human-infecting influenza A (H7N9) virus

Nature communications, 2014-01, Vol.5 (1), p.3142-3142, Article 3142

2014

Volltextzugriff (PDF)

Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort

Frontiers in immunology, 2022-01, Vol.13, p.829665-829665

2022

Volltextzugriff (PDF)

An evaluation of a test-negative design for EV-71 vaccine from a randomized controlled trial

Human vaccines & immunotherapeutics, 2021-07, Vol.17 (7), p.2101-2106

2021

Volltextzugriff (PDF)

Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants

Emerging microbes & infections, 2022-12, Vol.11 (1), p.2689-2697

2022

Volltextzugriff (PDF)

Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2

Protein & cell, 2021-09, Vol.12 (9), p.734-740

2021

Volltextzugriff (PDF)

A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9

Chinese medical journal, 2022-04, Vol.135 (7), p.799-805

2022

Volltextzugriff (PDF)

Precision immunization: a new trend in human vaccination

Human vaccines & immunotherapeutics, 2020-03, Vol.16 (3), p.513-522

2020

Volltextzugriff (PDF)

Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis

Frontiers in immunology, 2020-11, Vol.11, p.595970-595970

2020

Volltextzugriff (PDF)

1 – 25 von 230

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(211)
Mit Volltextzugriff
(193)

Publikationsform

Sprache

Englisch
(217)
Chinesisch
(13)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(178)
Life Sciences & Biomedicine
(138)
Humans
(99)
Immunology
(73)
Female
(55)
Infectious Diseases
(49)
Male
(49)
Adult
(42)
Biotechnology & Applied Microbiology
(36)
Immunogenicity
(36)
Middle Aged
(36)
Vaccines
(36)
China
(29)
Microbiology
(29)
Safety
(29)
Adolescent
(28)
Vaccination
(28)
Viruses
(28)
Antibodies, Viral - Blood
(25)
Covid-19
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Human Vaccines & Immunotherapeutics
(35)
Plos One
(11)
Emerging Microbes & Infections
(8)
Zhōnghuá Liúxíngbìng Zázhì
(8)
Frontiers In Immunology
(6)
China Cdc Weekly
(5)
Nature Communications
(5)
The Lancet
(5)
Vaccine
(5)
Virology
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial

Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study

Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need

Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China

CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2

Structures of Echovirus 30 in complex with its receptors inform a rational prediction for enterovirus receptor usage

A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)

Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial

Serotype specific epitopes identified by neutralizing antibodies underpin immunogenic differences in Enterovirus B

Research progress in the off-target effects of Bacille Calmette-Guérin vaccine

Advances in the progress of monoclonal antibodies for rabies

HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV

COVID-19 in children: epidemic issues and candidate vaccines

Rapid and Sensitive Detection of Salmonella spp. Using CRISPR-Cas13a Combined With Recombinase Polymerase Amplification

Ebola vaccines in clinical trial: The promising candidates

The performance of licensed rotavirus vaccines and the development of a new generation of rotavirus vaccines: a review

An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Dynamic reassortments and genetic heterogeneity of the human-infecting influenza A (H7N9) virus

Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort

An evaluation of a test-negative design for EV-71 vaccine from a randomized controlled trial

Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants

Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2

A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9

Precision immunization: a new trend in human vaccination

Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis

Suchergebnisse filtern